News Center

On December 12th, at the closing ceremony of the prestigious French Finance congress, Financium, Aymeric Le Chatelier,…

​A New Year has come​ and it's a wonderful time to reflect on what matters…

On Friday, 23rd November, Ipsen France celebrated a significant milestone by signing the Cancer & Employment Charter…

Ipsen, a leading  biopharmaceutical group  dedicated to improving lives through innovative medicines in specialty care (oncology , neuroscience and rare diseases) and…

Prior to joining Ipsen in 2016 as Chief Executive Officer, I lived in a number…

10/18/2018 By Bartek BEDNARZ, Senior Vice-President, Oncology Franchise In the past 12 months we are…

October is Liver Cancer Awareness Month, a global initiative that aims to raise understanding of…

Ipsen is delighted to join the Biotechnology Innovation Organization (BIO), the largest association of…

Paris (France), 27 September 2018 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointments of Dr.…

Ipsen Pharma GmbH, the German subsidiary of the global specialty-driven biopharmaceutical group Ipsen, has been…

Sunday 3rd June Today I’m giving the keynote speech at the second Boston-Paris Biotechnology Summit – this year…